FDA's Final Rule on Laboratory-Developed Tests (LDTs) and Phase-Out Policy

The FDA announced its Final Rule on laboratory-developed tests (LDTs), considering them as regulated medical devices. The phased-out policy will gradually enforce compliance with premarket review, quality system regulation, and other requirements over several stages. Additionally, a limited enforcem

0 views • 6 slides